Fatty acid synthase inhibition alleviates lung fibrosis via β-catenin signal in fibroblasts
Life Science Alliance · 2025
DOI: 10.26508/lsa.202402805 ↗Kurz gefasst
Fachartikel in der Zeitschrift Life Science Alliance, 2025. Verfasst von Hui Lian und 13 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Cell Differentiation and Regulation, Henan International Joint Laboratory of Pulmonary Fibrosis, Henan Center for Outstanding…. Hauptthemen laut MEDLINE: Fibroblasts, beta Catenin, Wnt Signaling Pathway, Bleomycin. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The Ministry of Science and Technology, Key R&D Program of Henan province, Zhongyuan scholar.
Abstract (Originalsprache)
Idiopathic pulmonary fibrosis is a progressive and lethal interstitial lung disease with an unclear etiology and limited treatment options. Fatty acid synthase (FASN) plays various roles in metabolic-related diseases. This study demonstrates that FASN expression is increased in fibroblasts from the lung tissues of patients with idiopathic pulmonary fibrosis and in bleomycin-treated mice. In MRC-5 cells, the inhibition of FASN using shRNA or the pharmacological inhibitor C75 resulted in the increased mRNA and protein expression of glycogen synthase kinase 3β and Axin1, both negative regulators of the Wnt/β-catenin signaling pathway, and promoted autophagy. This outcome led to a decrease in β-catenin protein and mRNA levels, effectively inhibiting the proliferation, migration, and differentiation of lung fibroblasts into myofibroblasts, while inducing the differentiation of fibroblasts into adipofibroblasts. In vivo experiments showed that C75 alleviated bleomycin-induced lung fibrosis in mice by inhibiting β-catenin. In conclusion, these findings suggest that inhibiting FASN in fibroblasts may diminish the activity of the Wnt/β-catenin signaling pathway, providing a potential therapeutic avenue for pulmonary fibrosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Cell Differentiation and Regulation, Henan International Joint Laboratory of Pulmonary Fibrosis, Henan Center for Outstanding Overseas Scientists of Organ Fibrosis, Pingyuan Laboratory, College o…
- Department of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Xinxiang Medical University, Weihui, China.
ORCID-Profile: Kai Xu, Lan Wang, Guoying Yu
Förderung
- The Ministry of Science and Technology
- Key R&D Program of Henan province
- Zhongyuan scholar
- Henan Project of Science and Technology
Zitieren
APA
Lian, H., Zhang, Y., Zhu, Z., Wan, R., Wang, Z., Yang, K., Ma, S., Wang, Y., Xu, K., Cheng, L., Zhao, W., Li, Y., Wang, L., & Yu, G. (2025). Fatty acid synthase inhibition alleviates lung fibrosis via β-catenin signal in fibroblasts. Life Science Alliance. https://doi.org/10.26508/lsa.202402805
Vancouver
Lian H, Zhang Y, Zhu Z, Wan R, Wang Z, Yang K, et al. Fatty acid synthase inhibition alleviates lung fibrosis via β-catenin signal in fibroblasts. Life Science Alliance. 2025. doi:10.26508/lsa.202402805
BibTeX
@article{Lian2025,
author = {Lian, Hui and Zhang, Yujie and Zhu, Zhao and Wan, Ruyan and Wang, Zhixia and Yang, Kun and Ma, Shuaichen and Wang, Yaxuan and Xu, Kai and Cheng, Lianhui and Zhao, Wenyu and Li, Yajun and Wang, Lan and Yu, Guoying},
title = {Fatty acid synthase inhibition alleviates lung fibrosis via β-catenin signal in fibroblasts},
journal = {Life Science Alliance},
year = {2025},
doi = {10.26508/lsa.202402805}
}
EUVIMED